Vellena 75+30 mikrogram overtrukne tabletter Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

vellena 75+30 mikrogram overtrukne tabletter

actavis group ptc ehf. - ethinylestradiol, gestoden - overtrukne tabletter - 75+30 mikrogram

Denise 150+30 mikrogram tabletter Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

denise 150+30 mikrogram tabletter

2care4 aps - desogestrel, ethinylestradiol - tabletter - 150+30 mikrogram

Alunbrig Európai Unió - dán - EMA (European Medicines Agency)

alunbrig

takeda pharma a/s - brigatinib - carcinom, ikke-småcellet lunge - antineoplastiske midler - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.

Lorviqua Európai Unió - dán - EMA (European Medicines Agency)

lorviqua

pfizer europe ma eeig - lorlatinib - carcinom, ikke-småcellet lunge - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.

Copiktra Európai Unió - dán - EMA (European Medicines Agency)

copiktra

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Ozawade Európai Unió - dán - EMA (European Medicines Agency)

ozawade

bioprojet pharma - pitolisant - sleep apnea, obstructive - andre narkotika stoffer - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).